Stealth BioTherapeutics Corp. - ADS (MITO): Price and Financial Metrics
MITO Price/Volume Stats
| Current price | $0.32 | 52-week high | $1.03 |
| Prev. close | $0.32 | 52-week low | $0.16 |
| Day low | $0.32 | Volume | 1,299,700 |
| Day high | $0.33 | Avg. volume | 946,105 |
| 50-day MA | $0.32 | Dividend yield | N/A |
| 200-day MA | $0.38 | Market Cap | 23.54M |
MITO Stock Price Chart Interactive Chart >
Stealth BioTherapeutics Corp. - ADS (MITO) Company Bio
A biopharmaceutical company developing therapies to treat the mitochondrial dysfunction associated with genetic mitochondrial diseases and many common age-related diseases.
Latest MITO News From Around the Web
Below are the latest news stories about Stealth BioTherapeutics Corp that investors may wish to consider to help them evaluate MITO as an investment opportunity.
Stealth BioTherapeutics Corp (MITO) CEO Reenie McCarthy on Q4 2020 Results - Earnings Call TranscriptStealth BioTherapeutics Corp (MITO) Q4 2020 Results Earnings Conference Call April 06, 2021, 08:30 AM ET Company Participants Henry Hess - Chief Legal Counsel Reenie McCarthy - Chief Executive Officer Jim Carr - Chief Clinical Development Officer Rob Weiskopf - Chief Financial Officer Brian Blakey - Chief Business Officer Conference... |
MITO Price Returns
| 1-mo | N/A |
| 3-mo | N/A |
| 6-mo | N/A |
| 1-year | N/A |
| 3-year | -73.33% |
| 5-year | -97.81% |
| YTD | N/A |
| 2023 | N/A |
| 2022 | 0.00% |
| 2021 | -44.48% |
| 2020 | -54.14% |
| 2019 | N/A |
Loading social stream, please wait...